12:00 AM
Nov 09, 2009
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Advanced Cancer Therapeutics preclinical data

Researchers at the University of Louisville published in Oncogene that selective inhibition of choline kinase (CHK) expression simultaneously attenuated two cellular signaling pathways...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >